This section brings together abstracts illustrating the broad interface between pathology, clinical oncology, and data-informed decision-making.The contributions combine diagnostic evaluation, biomarker analysis, clinicopathological characterisation, recurrence modelling, and supportive care, reflecting a field in which pathological information increasingly serves as a foundation for prognosis, treatment selection, and longitudinal patient management.A prominent thematic line concerns the diagnostic and predictive value of pathological and laboratory-derived markers.Two studies illustrate the continuing transition from descriptive pathology toward more clinically actionable prediction.Another important area of focus is clinicopathological characterisation at the time of diagnosis and treatment.The section includes analysis of the presenting manifestations of primary brain tumours, highlighting the heterogeneity of neuro-oncological symptoms and the diagnostic relevance of focal neurological deficits.
Ilmārs Stonāns (Wed,) studied this question.